Advances in CAR T cell immunotherapy for paediatric brain tumours
Brain tumours are the most common solid tumour in children and the leading cause of cancer related death in children. Current treatments include surgery, chemotherapy and radiotherapy. The need for aggressive treatment means many survivors are left with permanent severe disability, physical, intelle...
Main Authors: | Padmashree Rao, Liam Furst, Deborah Meyran, Chelsea Mayoh, Paul J. Neeson, Rachael Terry, Dong-Anh Khuong-Quang, Theo Mantamadiotis, Paul G. Ekert |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-11-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.873722/full |
Similar Items
-
Enhancing the Potential of Immunotherapy in Paediatric Sarcomas: Breaking the Immunosuppressive Barrier with Receptor Tyrosine Kinase Inhibitors
by: Emmy D. G. Fleuren, et al.
Published: (2021-11-01) -
Chimeric Antigen Receptor T cell Therapy and the Immunosuppressive Tumor Microenvironment in Pediatric Sarcoma
by: Rachael L. Terry, et al.
Published: (2021-09-01) -
A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
by: Chelsea Mayoh, et al.
Published: (2023-04-01) -
Diffuse leptomeningeal glioneuronal tumour (DLGNT) in children: the emerging role of genomic analysis
by: Neevika Manoharan, et al.
Published: (2021-09-01) -
126 Early-phenotype Lewis Y CAR-T cells persist better in vivo and induce solid tumor regression in combination with anti-PD1
by: Deborah Meyran, et al.
Published: (2020-11-01)